Cargando…

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research

BACKGROUND: The costs of performing research are an important input in value of information (VOI) analyses but are difficult to assess. OBJECTIVE: The aim of this study was to investigate the costs of research, serving two purposes: (1) estimating research costs for use in VOI analyses; and (2) deve...

Descripción completa

Detalles Bibliográficos
Autores principales: van Asselt, Thea, Ramaekers, Bram, Corro Ramos, Isaac, Joore, Manuela, Al, Maiwenn, Lesman-Leegte, Ivonne, Postma, Maarten, Vemer, Pepijn, Feenstra, Talitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775385/
https://www.ncbi.nlm.nih.gov/pubmed/28933003
http://dx.doi.org/10.1007/s40273-017-0572-7
_version_ 1783293895281475584
author van Asselt, Thea
Ramaekers, Bram
Corro Ramos, Isaac
Joore, Manuela
Al, Maiwenn
Lesman-Leegte, Ivonne
Postma, Maarten
Vemer, Pepijn
Feenstra, Talitha
author_facet van Asselt, Thea
Ramaekers, Bram
Corro Ramos, Isaac
Joore, Manuela
Al, Maiwenn
Lesman-Leegte, Ivonne
Postma, Maarten
Vemer, Pepijn
Feenstra, Talitha
author_sort van Asselt, Thea
collection PubMed
description BACKGROUND: The costs of performing research are an important input in value of information (VOI) analyses but are difficult to assess. OBJECTIVE: The aim of this study was to investigate the costs of research, serving two purposes: (1) estimating research costs for use in VOI analyses; and (2) developing a costing tool to support reviewers of grant proposals in assessing whether the proposed budget is realistic. METHODS: For granted study proposals from the Netherlands Organization for Health Research and Development (ZonMw), type of study, potential cost drivers, proposed budget, and general characteristics were extracted. Regression analysis was conducted in an attempt to generate a ‘predicted budget’ for certain combinations of cost drivers, for implementation in the costing tool. RESULTS: Of 133 drug-related research grant proposals, 74 were included for complete data extraction. Because an association between cost drivers and budgets was not confirmed, we could not generate a predicted budget based on regression analysis, but only historic reference budgets given certain study characteristics. The costing tool was designed accordingly, i.e. with given selection criteria the tool returns the range of budgets in comparable studies. This range can be used in VOI analysis to estimate whether the expected net benefit of sampling will be positive to decide upon the net value of future research. CONCLUSION: The absence of association between study characteristics and budgets may indicate inconsistencies in the budgeting or granting process. Nonetheless, the tool generates useful information on historical budgets, and the option to formally relate VOI to budgets. To our knowledge, this is the first attempt at creating such a tool, which can be complemented with new studies being granted, enlarging the underlying database and keeping estimates up to date. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40273-017-0572-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5775385
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-57753852018-01-30 Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research van Asselt, Thea Ramaekers, Bram Corro Ramos, Isaac Joore, Manuela Al, Maiwenn Lesman-Leegte, Ivonne Postma, Maarten Vemer, Pepijn Feenstra, Talitha Pharmacoeconomics Original Research Article BACKGROUND: The costs of performing research are an important input in value of information (VOI) analyses but are difficult to assess. OBJECTIVE: The aim of this study was to investigate the costs of research, serving two purposes: (1) estimating research costs for use in VOI analyses; and (2) developing a costing tool to support reviewers of grant proposals in assessing whether the proposed budget is realistic. METHODS: For granted study proposals from the Netherlands Organization for Health Research and Development (ZonMw), type of study, potential cost drivers, proposed budget, and general characteristics were extracted. Regression analysis was conducted in an attempt to generate a ‘predicted budget’ for certain combinations of cost drivers, for implementation in the costing tool. RESULTS: Of 133 drug-related research grant proposals, 74 were included for complete data extraction. Because an association between cost drivers and budgets was not confirmed, we could not generate a predicted budget based on regression analysis, but only historic reference budgets given certain study characteristics. The costing tool was designed accordingly, i.e. with given selection criteria the tool returns the range of budgets in comparable studies. This range can be used in VOI analysis to estimate whether the expected net benefit of sampling will be positive to decide upon the net value of future research. CONCLUSION: The absence of association between study characteristics and budgets may indicate inconsistencies in the budgeting or granting process. Nonetheless, the tool generates useful information on historical budgets, and the option to formally relate VOI to budgets. To our knowledge, this is the first attempt at creating such a tool, which can be complemented with new studies being granted, enlarging the underlying database and keeping estimates up to date. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40273-017-0572-7) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-09-20 2018 /pmc/articles/PMC5775385/ /pubmed/28933003 http://dx.doi.org/10.1007/s40273-017-0572-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
van Asselt, Thea
Ramaekers, Bram
Corro Ramos, Isaac
Joore, Manuela
Al, Maiwenn
Lesman-Leegte, Ivonne
Postma, Maarten
Vemer, Pepijn
Feenstra, Talitha
Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
title Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
title_full Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
title_fullStr Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
title_full_unstemmed Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
title_short Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
title_sort research costs investigated: a study into the budgets of dutch publicly funded drug-related research
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775385/
https://www.ncbi.nlm.nih.gov/pubmed/28933003
http://dx.doi.org/10.1007/s40273-017-0572-7
work_keys_str_mv AT vanasseltthea researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT ramaekersbram researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT corroramosisaac researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT jooremanuela researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT almaiwenn researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT lesmanleegteivonne researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT postmamaarten researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT vemerpepijn researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch
AT feenstratalitha researchcostsinvestigatedastudyintothebudgetsofdutchpubliclyfundeddrugrelatedresearch